Evidence map›Paper›PMID 36193815›Full record

ReviewChemical Society reviews2022

Multivalent glycocyclopeptides: conjugation methods and biological applications.

David Goyard, Angela Martin-Serrano Ortiz, Didier Boturyn, Olivier Renaudet

Open access · hybridAbstract readReview
In one paragraph

Review in Chemical Society reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David GoyardUniv. Grenoble Alpes, CNRS, DCM UMR 5250, F-38000 Grenoble, France. olivier.renaudet@univ-grenoble-alpes.fr.ORCID http://orcid.org/0000-0002-6410-0866
Angela Martin-Serrano OrtizUniv. Grenoble Alpes, CNRS, DCM UMR 5250, F-38000 Grenoble, France. olivier.renaudet@univ-grenoble-alpes.fr.ORCID http://orcid.org/0000-0002-2908-8910
Didier BoturynUniv. Grenoble Alpes, CNRS, DCM UMR 5250, F-38000 Grenoble, France. olivier.renaudet@univ-grenoble-alpes.fr.ORCID http://orcid.org/0000-0003-2530-0299
Olivier RenaudetUniv. Grenoble Alpes, CNRS, DCM UMR 5250, F-38000 Grenoble, France. olivier.renaudet@univ-grenoble-alpes.fr.ORCID http://orcid.org/0000-0003-4963-3848
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Click chemistry was extensively used to decorate synthetic multivalent scaffolds with glycans to mimic the cell surface glycocalyx and to develop applications in glycosciences. Conjugation methods such as oxime ligation, copper(I)-catalyzed alkyne-azide cycloaddition, thiol-ene coupling, squaramide coupling or Lansbury aspartylation proved particularly suitable to achieve this purpose. This review summarizes the synthetic strategies that can be used either in a stepwise manner or in an orthogonal one-pot approach, to conjugate multiple copies of identical or different glycans to cyclopeptide scaffolds (namely multivalent glycocyclopeptides) having different size, valency, geometry and molecular composition. The second part of this review will describe the potential of these structures to interact with various carbohydrate binding proteins or to stimulate immunity against tumor cells.

Indexed as

AzidesCopperAlkynesClick ChemistryOximesPeptides, CyclicPolysaccharidesSulfhydryl CompoundsAlkynesAzidesCopperOximesPeptides, CyclicPolysaccharidesSulfhydryl Compounds

Identifiers

PMID36193815
PMCPMC9575389
OpenAlexW4301392493

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.